Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 318 Colonic Neoplasms 90 Rectal Neoplasms 82 Neoplasm Metastasis 42 Pancreatic Neoplasms 40 Carcinoma, Non-Small-Cell Lung 35 Esophageal Neoplasms 25 Neoplasms 21 Stomach Neoplasms 20 Esophageal Squamous Cell Carcinoma 14 Adenocarcinoma Of Esophagus 12 Squamous Cell Carcinoma of Head and Neck 11 Lung Neoplasms 11 Head and Neck Neoplasms 11 Colorectal Cancer Metastatic 11 Breast Neoplasms 9 Gastrointestinal Neoplasms 7 Ovarian Neoplasms 6 Anus Neoplasms 6 Hereditary Sensory and Autonomic Neuropathies 5 Endometrial Neoplasms 5 Cholangiocarcinoma 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Triple Negative Breast Neoplasms 4 Salivary Gland Neoplasms 4 Recurrence 4 Digestive System Neoplasms 4 Advanced Colorectal Cancer 4 Tongue Neoplasms 3

Interventions

Chemoradiotherapy 2 Radiation 1 Paclitaxel 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Colony-Stimulating Factors 1 Cetuximab 1 Carboplatin 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable Esophageal Cancer × Cetuximab × Gastrointestinal × Clear all

NCT00827671 2018-03-09

TRACC

UMC Utrecht

Phase 2 Terminated

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡